NY A06778

Allows licensed pharmacists to prescribe, administer, and dispense Schedule III, IV, and V controlled substances for treating opioid use disorders in the course of professional pharmacy practice.

Permits licensed pharmacists to prescribe FDA-approved medication assisted therapy (buprenorphine) under non-patient-specific regimens for opioid use disorder treatment.

Requires pharmacists prescribing medication assisted treatment to register with the federal Drug Enforcement Administration, complete required training under the Controlled Substances Act, and report administrations to patients' primary health care practitioners.

Authorizes licensed physicians and certified nurse practitioners to prescribe non-patient-specific regimens to pharmacists for buprenorphine prescribing to opioid use disorder patients.

Directs the Commissioner of Health to establish a statewide protocol for pharmacist prescribing of medication assisted treatment within 90 days of the law's effective date, with the law taking effect 180 days after enactment.